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ABSTRACT
We describe an optimized microarray method for
identifying genome-wide CpG island methylation
called microarray-based methylation assessment
of single samples (MMASS) which directly compares
methylated to unmethylated sequences within a
single sample. To improve previous methods we
used bioinformatic analysis to predict an optimized
combination of methylation-sensitive enzymes that
had the highest utility for CpG-island probes and
different methods to produce unmethylated repres-
entations of test DNA for more sensitive detection of
differential methylation by hybridization. Subtraction
or methylation-dependent digestion with McrBC
was used with optimized (MMASS-v2) or previously
described (MMASS-v1, MMASS-sub) methylation-
sensitive enzyme combinations and compared with
a published McrBC method. Comparison was per-
formed using DNA from the cell line HCT116. We
show that the distribution of methylation microarray
data is inherently skewed and requires exogenous
spiked controls for normalization and that analysis
of digestion of methylated and unmethylated control
sequences together with linear fit models of
replicate data showed superior statistical power
for the MMASS-v2 method. Comparison with pre-
vious methylation data for HCT116 and validation
of CpG islands from PXMP4, SFRP2, DCC, RARB
and TSEN2 confirmed the accuracy of MMASS-v2
results. The MMASS-v2 method offers improved
sensitivity and statistical power for high-throughput
microarray identification of differential methylation.
INTRODUCTION
Epigenetic changes are heritable changes that include
reversible covalent modifications of histone proteins and
methylation of DNA. The vast majority of mammalian DNA
methylation is located at the cytosine of CpG dinucleotides
which are particularly frequent within CpG islands. The
definition of a CpG island continues to evolve but the follow-
ing criteria are currently accepted (1): a length >500 bp,
G + C content >50% and CpG dinucleotides at an observed-
to-expected ratio >0.60. Approximately 70% of mammalian
genomic CpG dinucleotides are methylated and commonly
occur within repetitive elements (2). In contrast, most
unmethylated CpG islands span the promoter regions
of house-keeping genes and tumour suppressor genes
and are critical in gene expression regulation and cell
differentiation (3).
The number of cancer-related genes inactivated by epigen-
etic modifications may equal or exceed the number inactiv-
ated by genetic mutations or allele loss (4–10). Therefore,
the development of high-throughput methods to characterize
methylated and unmethylated CpG islands in normal and
neoplastic tissues is vital to enable discovery of methylation
markers for cancer predisposition as well as understanding
the role of DNA methylation in neoplastic progression and
drug resistance (9–11).
Differential methylation hybridization (DMH) is an array-
based method for comparing the methylation status of CpG
islands between test samples and a common reference (12–
17). The two DNAs are first digested with MseI to reduce
the size of genomic fragments followed by a combination
of methylation-sensitive enzymes that only restrict unmethyl-
ated recognition sequences. The MseI recognition sequence
(TTAA) is found frequently within bulk DNA, but is rarely
found within CpG islands which remain intact after digestion
(18). Subsequent linker-mediated PCR results in amplicons
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that are enriched for methylated sequences. The labelled
amplicons are competitively hybridized and the ratio of test
to reference signal intensities at each probe on the array
reflects methylation differences between the two samples.
Nouzova et al. (19) modified this method by using digestion
with a methylation-dependent enzyme, the homing endo-
nuclease McrBC. This enzyme has a degenerate methylation
recognition sequence that only cleaves methylated DNA and
is very frequent in CpG islands. Amplicons from digested
DNA therefore represent unmethylated sequences, and com-
petitive hybridization of amplicons from McrBC digested
and undigested DNA from the same sample was used to
identify methylated sequences by within-sample comparison.
This avoided the need for a common reference design
which is advantageous for profiling clinical samples where
no appropriate reference tissue may be available or where
the available reference sample may not have a ‘normal’
methylation pattern. However, a potential disadvantage of
the Nouzova et al. (19) method is that there is unequal repres-
entation of methylated and unmethylated sequences in a sin-
gle hybridization and this may reduce sensitivity to detect
differential methylation.
Previous DMH profiling studies used microarrays for
which the full sequences of the probes, and consequently
their restriction map sites, were unknown (12–17). This pre-
vented rational design of the digestion steps and rigorous ana-
lysis of probe performance to exclude artefactual errors (16).
For example, if a probe sequence lacks the restriction site for
a methylation-sensitive enzyme that digests unmethylated
target, the signal from this probe will be falsely assigned as
methylated. In this work, we used bioinformatic tools to
provide detailed annotation of all probes on a publicly avail-
able CpG island array and used this information to develop
and validate a high-throughput method called microarray
methylation assessment of a single sample (MMASS). We
show that MMASS offers improved sensitivity to profile
methylated as well as unmethylated CpG islands from single
samples.
MATERIALS AND METHODS
Cell line
HCT116 colon cancer cells were cultured in McCoy’s 5A
modified medium supplemented with 10% foetal bovine
serum and 1% penicillin/streptomycin. High-molecular
weight DNA was isolated using standard proteinase K and
phenol extraction methods.
Derivation of probe sequences and preparation
of spike control DNA
Human CpG island arrays containing 13 056 features
(HCGI12K) were obtained from the Microarray Centre,
University Health Network, Toronto, Canada (http://
www.microarrays.ca/products/types.html#HCGI12K). End
sequences for the CpG island probes were obtained from
the Sanger Centre (available from http://www.sanger.ac.uk/
HGP/cgi.shtml) and aligned by BLAST (20) against the
NCBI v.35 human genome assembly. Each probe sequence
was predicted from contiguous sequence tag alignments
containing two MseI recognition sites as MseI digestion
was used to create the CpG island library (18). Sequences
were further annotated with PERL scripts using BioPerl
libraries (21) together with data and libraries from
Ensemble (22) (Supplementary Table 1 and Supplementary
Perl scripts 1–3). Repetitive sequences were identified using
repeatmasker (http://www.repeatmasker.org).
Spike control amplicons were prepared by PCR from DNA
extracted from normal blood. Methylated spikes were methyl-
ated in vitro using SssI (New England Biolabs) following the
manufacturer’s instructions and methylation was confirmed
by digestion with appropriate methylation-sensitive enzymes
and gel electrophoresis. Methylated and unmethylated spikes
were added to the samples before MseI digestion at concen-
trations corresponding to 1–1000 copies (Supplementary
Table 2).
Preparation of genomic DNA
Genomic representation of methylated and unmethylated
sequences by enzyme digestion. The MMASS-v1 and
MMASS-v2 methods used methylation-sensitive and
methylation-dependent enzyme digestion for within-sample
comparison (Figure 1). Genomic DNA (2 mg for MMASS-
v1 and 1.2 mg for MMASS-v2 methods) was digested over-
night in a 30 ml volume using 20 U MseI at 37C. Digested
DNA was then ligated to the linkers H-14 50-tactccctcggata-
30 and H-24 50-aggcaactgtgctatccgagggag-30 which prevented
reconstitution of the MseI site. Ligation was carried out in a
mixture comprising 30 ml MseI digested DNA, 16 mM
annealed linkers, 10· ligase buffer, 1.5 ml of 10 mM ATP,
6 ml PEG 6000, 400 U T4 DNA ligase and 10 U MseI in a
total volume of 60 ml at 20C for 4 h. The ligated DNA frag-
ments were purified using the Qiaquick PCR purification kit
(Qiagen), eluted in 100 ml water and vacuum dried. For rep-
resentation of unmethylated sequences, half the sample was
restricted with McrBC, after resuspension in 40 ml water
with 10· NEB buffer 2, 10· GTP, 10· BSA and 20 U
McrBC at 37C for 4 h. For representation of methylated
sequences, the other half of the sample was restricted by
either the combination of BstUI, HhaI and HpaII (MMASS-
v1) in a volume of 30 ml (17) or the combination of AciI,
HinP1I, HpyCH4IV and HpaII (MMASS-v2) in a volume
of 70 ml with 10· NEB buffer 1, 10· BSA and 20 U of
each of the enzymes. A further 10 U of each enzyme was
added after 4 h for the MMASS-v2 method and the reaction
was allowed to continue for a further 2 h.
Genomic representation of unmethylated sequences by
subtraction. The MMASS-sub method used subtractive
hybridization to obtain the unmethylated representation
from the starting DNA (Figure 1). Amplicons representing
methylated CpG islands were prepared using the MMASS-
v1 method as above by digesting 2 mg of DNA and using
both halves for methylation-sensitive enzyme digestion.
One amplicon was then used as the subtractor DNA from
an additional 1 mg of the test DNA digested with MseI.
Subtraction was performed using biotin-labelling (BioNick
Labeling System; Invitrogen) of the subtracter DNA and
recovery with streptavidin-coated magnetic particles (Strep-
tavidin Magnetic Particles; Roche Diagnostics) following
the manufacturer’s recommendations and as described
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previously (23). The resulting subtracted DNA (unmethylated
representation) was then amplified as below before being
hybridized against the remaining methylated amplicon.
Representation using Nouzova method
The Nouzova et al. (19) method was carried using both indir-
ect labelling (see below) and as described previously using
direct incorporation of Cy3- or Cy5-labelled dCTP and co-
hybridization with Cot-1 DNA.
PCR amplification
Each restricted DNA sample was purified using a Qiaquick
PCR purification column (Qiagen) and eluted in 100 ml
water. PCR amplification was performed in a 300 ml volume
comprising 100 ml digested DNA, 10· thermo-start buffer
(Applied Biosystems), 100 mM MgCl, 25% DMSO,
200 mM Betaine (Sigma), 0.5 mM H-24 primer, 0.1 mM
dNTP mixture and 6 U Deep VentR (exo
) DNA polymerase
(New England Biolabs). The thermocycling conditions were
5 min at 72C to fill in the overhanging ends of the ligated
DNA fragments, followed by 21 cycles (25 cycles for the
MMASS-v2 method) of 1 min at 94C, 1 min at 65C and
3 min at 72C, with a final extension for 10 min at 72C.
Five microlitres of the PCR product was electrophoresed on
a 1.5% agarose gel and a diffuse smear pattern between
0.2 and 2kb was taken to indicate successful PCR amplifica-
tion as described previously (17).
Labelling and hybridization
For each methylated and unmethylated amplicon 300 ng of
PCR product was vacuum dried and resuspended in 33 ml
of water with 2.5· random primer buffer (BioPrime Labeling
Kit; Invitrogen) together with 0.5 ng of control Arabidopsis
thaliana cDNA (synthesized from pARAB obtained from
the Microarray Centre, University Health Network, Toronto,
Canada) and denatured at 95C for 5 min. Each denatured
sample was placed on ice with 7.5 ml of 10· dNTP mixture
(2 mM each of dATP, dCTP and dGTP, and 0.35 mM
dTTP), 1.8 ml of 10 mM aminoallyl-dUTP together with
80 U Klenow Fragment and incubated at 37C for 2 h then
stopped with 5 ml of stop buffer (BioPrime Kit). The total vol-
ume was increased to 425 ml with water and unincorporated
aminoallyl-dUTP was removed by two centrifugations at
10 000 r.p.m. using a Microcon YM30 concentrator (Milli-
pore). Purified sample was collected by centrifuging the
inverted column at 4500 r.p.m. for 5 min and then vacuum
dried. Each sample was reconstituted in 4.5 ml of water
together with 4.5 ml Cy dye (Amersham-Pharmacia Biotech)
TTAATTAA TTAA
Linker PCR
LabelLabel
Mix and hybridise
Linker PCR
Digest
unmethylated CpG
Digest
methylated CpG
MseI digestion and adaptor ligation
± control spikes
Mix and hybridise
Linker PCR
Digest
unmethylated CpG
Digest
unmethylated CpG
Linker PCR
Digest with MseI
Linker PCR
Label
Label
TTAATTAA TTAA
MseI digestion and adaptor ligation
± control spikes
Figure 1. MMASS method. (a) DNA from HCT116 was digested with MseI (restriction sequence TTAA) followed by adaptor ligation and addition of control
spikes as appropriate. (b) One-half of the sample was digested with McrBC (to cut methylated sequences) and the other by a combination of methylation-
sensitive enzymes (to cut unmethylated sequences). (c) Linker-mediated PCR resulted in two amplicons representing methylated and unmethylated sequences
which were (d) labeled then (e) mixed and hybridised to the CpG island array. For the MMASS-sub method, an amplicon representing methylated sequences
prepared as described above was subtracted from a MseI digested sample (f) resulting in DNA enriched for unmethylated sequences (g). The subtracted
preparation was subsequently amplified and competitively hybridized against a reciprocal amplicon (h).
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in 0.1M sodium bicarbonate titrated with sodium hydroxide
to pH 9.0. The mixture was held at room temperature in
the dark for 1.5 h and the coupling reaction was stopped by
adding 4.5 ml of 4M hydroxylamine and 35 ml of 100 mM
sodium acetate (pH 5.2). Labelled DNA was purified using
a Qiaquick PCR purification column and then vacuum
dried. Both dye-coupled DNAs were then resuspended
together in 85 ml of DIG Easy Hyb solution (Roche Diagnost-
ics) together with 5 ml of salmon sperm DNA (10 mg/ml) and
denatured at 95C for 5 min. The hybridization mixture was
allowed to cool briefly and 5 ml of yeast tRNA (10 mg/ml) was
added and the mixture was held at 65C for 2 min and
allowed to cool to room temperature. Hybridization to the
microarray was carried out under a cover slip in a humidified
chamber at 37C for 8 h. The cover slip was floated off in 1·
SSC and each slide was washed three times in 1· SSC and
0.1% SDS at 50C for 15 min followed by removal of SDS
at room temperature in 1· SSC and 0.1· SSC for 5 min
each. The slides were dried by centrifugation at 500 r.p.m.
for 5 min and scanned immediately using the GenePix
4000A scanner (Axon). The settings for PMT gain were
adjusted during the initial rapid scan to achieve a balance
between the two channels and these settings were used for
the high resolution scan. GenePix version 4.1 was used to
perform image analysis and feature segmentation.
COBRA
Sodium bisulphite conversion of HCT116 DNA was per-
formed as described previously (24,25). PCR was then per-
formed on bisulphite-modified DNA samples using primers
designed to amplify both methylated and unmethylated
DNA (Supplementary Table 3). This was followed by restric-
tion digestion using appropriate enzymes that contain CpG
within their recognition sequence as these will change in
the DNA samples if the original cytosine bases were
unmethylated and followed by quantification using electro-
phoresis on a 2.5% agarose gel.
Microarray analysis
The limma (26) package within the R environment (27) was
used to background-correct, normalize and analyse the data.
Where the background exceeded the foreground intensity,
the minimum background value for the array was subtracted
rather than the local background measurement of the spot.
We combined replicate dye-swap arrays for each method
using the linear model and empirical Bayes smoothing
procedures available in the limma package. A full transcript
of all statistical code and the results of computations are pro-
vided in the Supplementary Sweave document which allows
the analysis to be examined and repeated exactly (28–30).
The raw data from the array experiments is available from
the Gene Expression Omnibus (GEO; www.ncbi.nlm.nih.
gov/geo) under the series accession number GSE5326.
Calculation of spike statistics
For each spiked probe we obtained the spike, digestion and
non-digestion effect statistics which represented the spike
amount (compared to background level) and the amount
of the spike that was digested and undigested, respectively.
The spike effect was estimated from the difference in
log-intensities between the spiked and unspiked experiments.
For the comparisons between labelling methods, intensities
were obtained from the channel in which the spike was
not expected to be digested and averaged between arrays.
The digestion effect was defined as the difference in
log-ratios between the spiked (M0) and non-spiked (M)
arrays for methylated (Dmi ¼ M
0
i  Mi) and unmethylated
(Dui ¼ Mi  M
0
i) spiked probes (i), respectively.
RESULTS
Analysis of probe sequences
We first used bioinformatic methods to predict the complete
sequence for all probes on the CpG island arrays, as at the
start of the project only end-sequence tags were available
(18). The majority of the library was subsequently fully
sequenced by the University Health Network Microarray
Centre, Toronto (sequences available at http://derlab.med.
utoronto.ca/CpGIslands/). After BLAST comparison to the
human genome 5435 out of 13 056 (41.6%) probes were
selected that had a percentage identity of >97% and <30%
masked repeat elements and these were annotated as single
copy sequences. A further 1190 probes (9.1%) contained
100% repeat sequences and the remainder was either not
identifiable or had an intermediate percentage of repetitive
sequences. The restriction sites for all commercially available
methylation-sensitive enzymes were identified for unique
probes together with the distance to the nearest neighbouring
genes and the percentage and type of included repetitive
sequences (Supplementary Table 1).
From these analyses, we found that 4160 out of 5435
(76.5%) of the probes on the CpG array would be informative
when using the previously described combination of BstUI,
HpaII and HhaI enzymes to generated representations
of methylated target DNA (17). We predicted that using a
novel combination of four enzymes (AciI, HpaII, HinP1I
and HpyCH4IV) would utilize 4403 out of 5435 (81%) of
the array probes and therefore improve utility. In addition
this combination of enzymes was more convenient as all
four enzymes could digest efficiently in the same buffer. In
contrast, digestion with BstUI, HpaII and HhaI required a
two-step digestion protocol with an additional purification
step.
We hypothesized that the sensitivity of array-based
methylation detection could be improved if greater contrast
could be achieved between methylated and unmethylated
signal. We therefore evaluated two different methods for gen-
erating representations of unmethylated sequences. First, we
used McrBC to digest methylated DNA in one-half of the
sample for comparison against digestion with the combina-
tions of methylation-sensitive enzymes above (MMASS-v1
and MMASS-v2; Figure 1). Second, we used subtractive
hybridization using a subtractor DNA digested with BstUI,
HpaII and HhaI (MMASS-sub; Figure 1).
Exploratory data analysis
For each of the methods we obtained four microarray hybrid-
izations, using replicate biological preparations in a balanced
dye-swap design and compared the results to the method of
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Nouzova et al. (19). DNA from the colorectal cancer cell line
HCT116 was used for all experiments as methylation patterns
have been well characterized in this cell line (31,32).
The overall quality of individual hybridizations was
assessed by inspection of MA and spatial plots (33) for
each of the arrays (Figure 2 and Supplementary Sweave
document). Unsatisfactory array experiments were repeated
and 16 high-quality hybridizations were obtained from a
total of 19 experiments.
Log ratios (M) for control A.thaliana probes showed little
variation around M ¼ 0 indicating high reproducibility
(Figure 2). Inspection of blank spots showed uniform low
intensities as expected (Figure 2). In contrast to MA plots
from expression array and array CGH experiments, the distri-
bution of log-ratios from MMASS and Nouzova experiments
was not symmetrical. It is important to note that for the
Nouzova et al. (19) method the log-ratios should theoretically
all be positive, as a mixture of methylated and unmethylated
sequences was directly compared to unmethylated sequences.
Comparison between arrays showed that each method had
a characteristic distribution of data points on the MA plot
that was highly consistent between replicate experiments.
For the MMASS-v2 and the MMASS-sub methods there
was a bimodal distribution of log-ratios at higher probe
intensities (Figures 2 and 3) indicating increased separation
between methylated and unmethylated sequences.
We evaluated different strategies for optimum normali-
zation of each method and these are discussed in detail in
the Supplementary Sweave document. The A.thaliana probes
proved unreliable for location normalization except for the
MMASS-v2 method where pipetting error was well con-
trolled, allowing the use of median correction (Supplement-
ary Figure S1). Replicate arrays for the MMASS-v1 and
Nouzova methods were sufficiently comparable after global
loess normalization. For the MMASS-sub method, normaliza-
tion was performed using a subset of high-intensity methyl-
ated clones that demonstrated consistent log-ratios between
replicate arrays (Supplementary Figure S2).
Identification of differentially methylated probes
For each of the methods we fitted a linear model followed
by empirical Bayes smoothing to obtain B statistics (26,34)
so that probes could be ranked by the likelihood of differen-
tial methylation. Volcano plots summarizing the results
showed striking differences in the B statistics obtained from
Figure 2. MA plots of methylation profiling experiments. Columns show replicate arrays for the MMASS-v1, MMASS-v2, MMASS-sub and Nouzova et al. (19)
methods. Positive M values represent increased ratio of methylated sequences and negative M values increased ratio of unmethylated sequences (except for the
Nouzova et al. method where the negative M values are artefactual as no differential signal should be obtained from unmethylated sequences). A values represent
average fluorescence intensity. Coloured points are A.thaliana, green; mitochondrial DNA, purple; empty points, orange. Linear lines at low A values are
artefacts from background subtraction.
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each method (Figure 3). Most notably, the Nouzova method
gave a very low and limited range of B statistics demonstrat-
ing a lack of power to assess methylation. In contrast, the
MMASS-v2 and MMASS-sub methods resulted in much
higher B values indicating better assessment of methyla-
tion. However, compared to the MMASS-v2 method, the
MMASS-sub method was more variable as shown by the
wide spread of points with low B values in the MMASS-
sub method volcano plot (Figure 3). The MMASS-v2 method
resulted in markedly higher B values than the MMASS-v1
method. The poor discrimination of the Nouzova data was
surprising. To exclude artefact caused by our use of indirect
labelling or different hybridization conditions, we repeated
the original protocol exactly as described for four additional
arrays. No significant increase in performance was obtained
by using the unmodified protocol (Supplementary Sweave
document).
We next examined results for mitochondrial DNA and
repetitive element probes as these are known to be substan-
tially unmethylated and methylated, respectively (35–37).
The MA plots showed the mitochondrial DNA to be con-
sistently unmethylated in data from the MMASS methods
(Figure 2). However the Nouzova et al. (19) method had
poor sensitivity for distinguishing unmethylated mitochon-
drial genes. Ranking by B statistics showed that the top
unmethylated probes were mitochondrial DNA sequences
and that the most methylated probes were repeat elements
(Figure 4). It is important to note that as mitochondrial and
repetitive sequences are present in high copy number in the
genome (36) and over-represented on the HCG12K arrays
(see earlier), more consistent probe measurements would be
expected, making it easier to detect differential methylation
for these probes as compared to single copy genes.
We then assessed the effect of spiking in vitro methylated
and unmethylated target DNAs into the hybridization samples
as positive and negative controls for the detection of methyl-
ated and unmethylated sequences. We first labelled 32 can-
didate spikes and hybridized them to two HCGI12K arrays
to test the stringency of hybridization (Supplementary Figure
S3). Eight spikes which showed correct hybridization and had
the largest spike effects (Supplementary Figure S4) were
selected for further analysis. Adequacy of in vitro methyla-
tion was confirmed with BstUI digestion (Supplementary
Figure S5) and spikes that were poorly methylated or that
had inconsistencies between predicted and actual DNA
sequence were excluded from analysis. The spikes were
added to two hybridizations for each method leaving the
remaining two unspiked so that background measurements
for spiked probes could be established.
To quantify the amount by which the spikes were digested,
we calculated the spike effect at each of the four methylated
and unmethylated spiked probes and compared this to the
spike remaining after digestion (Figure 5 and Supplementary
Figure S4). For unmethylated spikes, the largest spike effect
was seen for probes shown in Figure 5g and h where almost
complete digestion by the MMASS-v1 and MMASS-v2
methods was observed. As expected there was minimal diges-
tion by the Nouzova et al. (19) method as McrBC does not
restrict unmethylated sequences. The spike effect at probes
shown in Figure 5 e and f was too small to allow meaningful
interpretation. For methylated spikes (Figure 5a–d) the
largest digestion effect was observed for the MMASS-sub
Figure 3. Correlation between COBRA and array methylation results. Plots show data from the linear model fitted to replicate arrays for each of the MMASS-v1,
MMASS-v2, MMASS-sub and Nouzova et al. (19) methods. MA plots (upper panel) and volcano plots (lower panel) are shown. Coloured probes
indicate validation results from COBRA analysis. Orange indicates confirmed as methylated and blue indicates unmethylated. Legend shows probe id. See also
Supplementary Table 3.
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and MMASS-v2 method. However the subtraction process
could also have attenuated the spiked sequences, increasing
the apparent effect. There was little digestion effect seen
for the Nouzova (19) and MMASS-v1 methods.
To validate the results for single copy genes, we selected
14 probes randomly within low, medium and high average
probe intensity (A) ranges and compared results from array
hybridizations from each MMASS method with independent
assessment by COBRA (Figure 3, Supplementary Figure S6
and Supplementary Table 3). Although COBRA only surveys
two to four CpGs in an amplicon, our experience in cancer
samples is that this gives a good indication of the methylation
status of the locus. Results from probes with A values higher
than the median intensity of the A.thaliana control spots
were more consistent with the COBRA results and these
higher intensity probes were also more consistent
across all MMASS methods (Figure 3 and Supplementary
Table 3).
The MMASS-sub method resulted in greatest separation
between the methylated and unmethylated COBRA validated
clones (Figure 3). The ranking of the MMASS probes by
degree of methylation was consistent with full and partial
methylation results detected by COBRA (Figure 3 and
Supplementary Table 3).
Validation of methylation of cancer-related genes
We then examined 325 single copy probes identified by
the MMASS-v2 method with values of B > 3 as this cut-
off was consistent with the COBRA validation experiments
gene
LINE1(GC=58%)
LINE1(GC=59%)
LINE1(GC=58%)
LINE1(GC=53%)
LINE1(GC=55%)
LINE1(GC=55%)
ALUs and LINE1(46%)
ALUs(GC=47%)
ALUs(GC=58%)
ALUs(GC=56%)
ALUs(GC=63%)
ALUs(GC=55%)
ALUs and LINE2(GC=48%)
LINE1(GC=55%)
LINE1(GC=56%)
ALUs(GC=52%)
ALUs(GC=47%)
ALUs and ERVL(GC=46%)
ALUs and ERV_1(GC=46%)
ALUs(GC=48%)
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
NADHubiquinone oxireduc.
NADHubiquinone oxireduc.
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome c oxidase polypeptide II
Cytochrome b.
Cytochrome c oxidase polypeptide II
–
5
0
10
5
–6 –4 –2 0 2
Figure 4. Mitochondrial and repetitive sequence probes show highest differential methylation. Volcano plot of linear fit model combining four experiments
using the MMASS-v2 method. The top 20 methylated and unmethylated sequences are plotted as vermilion and blue points respectively. Legend shows
probe type.
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(Supplementary Table 4). From these, 22 were selected that
were proximal to genes reported previously as having cancer-
related functions (Figure 6), including DNA replication and
repair (PMS2L4, MCM7 and BRCA1) and tumour suppressor
function in colorectal cancer (SFRP2) (38). Validation of the
methylation status of five CpG islands (PXMP4, SFRP2,
DCC, RARB and the unmethylated housekeeping gene
TSEN2) confirmed correct array results using COBRA or
MSP (Supplementary Figure S7). Our array result for
HNRPA2B1 (Figure 6) was not in agreement with previous
data that has shown it to be unmethylated in HCT116 (39)
but we were unable to obtain a satisfactory MSP result to
confirm this (data not shown). The reproducibility of the
MMASS-v2 method was also demonstrated by the finding
of very similar B values for several duplicate probes from sin-
gle copy genes, including MCM7 (Figure 6 and Supplement-
ary Figure S8).
We also examined array data from 23 probes representing
9 genes (SYK, ZFP37, DIRAS3, RARB, LMX1A, DAPK1,
SFRP2, FAT and RASSF1) that have been reported previously
to be methylated in HCT116 (32,40). Inspection of MA and
volcano plots for each of the four methods (Figure 7) showed
that the MMASS-v2 results were most consistent with previ-
ous data.
DISCUSSION
Genomic profiling of methylated and unmethylated sequences
using methylation-sensitive restriction enzyme digestion and
hybridization to microarrays is a potentially powerful and
convenient technique. However, in contrast to work carried
out on expression microarray data, no detailed assessment
of the effects of different protocols or analysis methods has
been performed (17,19,31,41,42). We have developed and
optimized new restriction enzyme methods to profile both
methylated and unmethylated sequences within a single
sample.
The three MMASS methods resulted in very consistent
data representation between replicate experiments but there
were marked differences in sensitivity. The MMASS-sub
method increased the power to resolve methylation dif-
ferences as compared to the previously published Nouzova
et al. (19) method, but also increased noise (Figure 3). The
subtraction steps were time consuming, and there remains a
theoretical disadvantage that the subtraction may compound
errors caused by partial digestion. For example, an excess
of the partially digested sequences in the subtracter DNA
amplicon could result in disproportionate removal of target
DNA and a skewed representation of methylation. The
MMASS-v2 method resulted in better representation of the
methylation status of the target DNA (Figure 7) and had
less noise, and therefore increased power, as compared to
other methods (Figures 3 and 7). This may be in part because
of better digestion of unmethylated sequences (Figure 5). As
additional fresh enzymes were added in the MMASS-v2
method and digestion was carried out in a single step using
one buffer–enzyme combination, minimizing potential loss
of sample.
The poor performance of the Nouzova et al. (19) method
was surprising and cannot be explained simply by technical
reasons, such as failure of McrBC digestion, as all exp-
eriments were carried out using the same conditions, batch
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Figure 5. Digestion of methylated and unmethylated spikes. Bar plot shows the spike effect averaged over all the methods (open bars) of methylated (upper
panel) and unmethylated (lower panel) spiked probes. Non-digestion effects (grey bars) for each probe are shown by method and should be compared to open
bars. Vertical lines over bars indicate 2 SEs around the mean.
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of enzyme and in vitro methylated spikes. In addition, the
dynamic range for probe data was very similar between our
Nouzova experiments and the original publication. It is pos-
sible that other effects such as array quality or the higher
genomic complexity of the amplicon from the undigested
DNA (containing unmethylated and methylated sequences)
may have altered spike-probe hybridization results. However
in contrast to MMASS, the Nouzova method has very poor
sensitivity for detecting hypomethylation (Figure 2) such as
mitochondrial spots.
The mixtures being compared by hybridization may
have had strong effects on sensitivity. The direct comparison
of methylated to unmethylated representations appears more
sensitive (larger M values) than comparisons to a mixture
of methylated and unmethylated sequences as in the Nouzova
et al. (19) method. The MMASS methods resolved with high
precision the methylation status for repetitive and mitochon-
drial target DNAs as these are represented in high copy num-
ber in the genome (Figure 4). They also were able to resolve
single copy CpG methylation and identify correctly the
methylation status of a number of CpG islands which have
been described previously to be methylated or unmethylated
in HCT116 (Figures 6 and 7).
The bioinformatic analysis of methylation array data is
very different to that of expression data in which symmetrical
distribution of log-ratios is assumed and the main aim of
normalization is to remove dye bias. We show here that
data distributions from different methods are inherently
skewed and may be bi-modal at high intensities. It is not
possible to estimate how much asymmetry to expect since
this will depend upon the method used and global levels of
methylation in the samples. We have carefully investigated
and applied appropriate methods for these analyses. From
these data it is clear that proper normalization is funda-
mentally reliant on exogenous controls including the spiked
A.thaliana cDNA used here, but better reagents are needed.
Significant collaborative efforts are now underway for
designing reproducible control spikes for expression studies
(43). It is important to note that use of simplistic location-
based normalization in other datasets is likely to have preven-
ted detection of real effects and combining probe-level data
between different datasets that have used different methods
and comparator DNAs may be impossible to achieve.
We were able to optimize our methods by using bioinform-
atic tools to identify and annotate the predicted probe
sequences on the HCGI12K array and to identify the
optimum set of restriction enzyme sites to maximize probe
utilization. Optimization of this enzyme set was based on
analysis of 5435 CpG island sequences and therefore likely
to be of high utility to other CpG island platforms. This
may also have contributed to the improved effects seen
with the MMASS-v2 method. However, our analysis was lim-
ited by the low number of informative probes caused by
inclusion of repeat and nonsense sequences from the original
library. Improved array platforms with better representation
of all CpG islands across the genome, as well as fine mapping
within individual CpG islands, are now needed for detailed
studies.
MMASS has several advantages over current high-
throughput methods; e.g. MMASS in common with DMH
employs a universal primer complementary to the ligated
adaptor rather than a complex sequence-specific primer
TSEN2
FOXD4L1
PCDH11X
PMS2L4
MCM7
MCM7
HECA
BRIP1
HSPA2
PXMP4
IKIP
HNRPA2B1
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Figure 6. Methylation results for 22 cancer-related probes in HCT116 using the MMASS-v2 method. Figure shows detail from volcano plot of linear fit model.
Legend shows gene symbols.
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design such as in methylation-specific oligonucleotide micro-
array (44) and MALDI mass spectrometry (45). Methylation
analysis using BAC microarrays requires the use of rare cut-
ting methylation-sensitive enzymes which limits resolution to
a single BAC probe, or only provides an average estimate of
methylation across a large genomic region (46,47). Other
methods that have used within-sample comparison methyla-
tion analysis have either used non-optimized enzyme com-
binations (48) or complex specific linker/enzyme pairings
that have not been shown to improve sensitivity (49).
MMASS is able to resolve the overall methylation status of
a single copy CpG island probe on a spectrum from mostly
unmethylated to mostly methylated. Our results also show
that in contrast to DMH and the Nouzova et al. (19) method,
we were able to detect unmethylated sequences such as
housekeeping genes (Figure 6). This will be particularly
important in the context of the human epigenome project
and for cancer studies where comparison is needed for both
methylated and unmethylated sequences (50).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR online.
ACKNOWLEDGEMENTS
A.E.K.I. conceived the study, conducted the microarray
experiments and drafted the manuscript. N.P.T. participated
in the study design as well as manuscript preparation and
conducted the analysis. K.B. helped in conducting the
microarray and COBRA experiments. N.L.B.M. annotated
the array platform sequences and wrote the Perl scripts used
for bioinformatic analysis. S.T. participated in data analysis
and manuscript preparation. V.P.C. participated in the
coordination of the study. A.H.W. participated in the
coordination of the study. M.J.A. participated in designing
and coordinating the study and manuscript preparation. J.D.B.
participated in designing the experiments, coordinating the
study, data analysis and manuscript preparation. All authors
read and approved the final manuscript. We thank Dr Koichi
Ichimura for technical advice on genomic hybridization
protocols. This work was funded by grants from Cancer
Research UK (CR-UK) and the Department of Pathology,
University of Cambridge. A.E.K.I. is a CR-UK Bobby Moore
Fellow and J.D.B. is a CR-UK Senior Clinical Research
Fellow. N.L.B.-M. is supported by a PhD Fellowship
(PRAXIS XXI SFRH/BD/2914/2000) from Fundac¸a˜o para a
Cieˆncia e a Tecnologia, Portugal. Funding to pay the Open
Access publication charges for this article was provided by
grants from Cancer Research-UK.
Conflict of interest statement. None declared.
REFERENCES
1. Wang,Y. and Leung,F.C.C. (2004) An evaluation of new criteria
for CpG islands in the human genome as gene markers. Bioinformatics,
20, 1170–1177.
2. Turker,M.S. and Bestor,T.H. (1997) Formation of methylation patterns
in the mammalian genome. Mutat. Res., 386, 119–130.
3. Bird,A. (2002) DNA methylation patterns and epigenetic memory.
Genes. Dev., 16, 6–21.
4. Jones,P.A. and Laird,P.W. (1999) Cancer epigenetics comes of age.
Nature Genet., 21, 163–167.
Figure 7. Methylation results for 9 genes (23 independent probes) reported previously to be methylated in HCT116. MA plots (upper panel) and volcano plots
(lower panel) of linear fit models for each method are shown. Probes representing the same gene are plotted with the same colour. Legend shows gene symbol
and probe id.
e136 Nucleic Acids Research, 2006, Vol. 34, No. 20 PAGE 10 OF 12
 by guest on A
ugust 26, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
5. Herman,J.G. (1999) Hypermethylation of tumor suppressor genes in
cancer. Semin. Cancer Biol., 9, 359–367.
6. Jones,P.A. and Baylin,S.B. (2002) The fundamental role of epigenetic
events in cancer. Nature Rev. Genet., 3, 415–428.
7. Merlo,A., Herman,J.G., Mao,L., Lee,D.J., Gabrielson,E., Burger,P.C.,
Baylin,S.B. and Sidransky,D. (1995) 50 CpG island methylation is
associated with transcriptional silencing of the tumour suppressor
p16/CDKN2/MTS1 in human cancers. Nature Med., 1, 686–692.
8. Herman,J.G., Latif,F., Weng,Y., Lerman,M.I., Zbar,B., Liu,S.,
Samid,D., Duan,D.S., Gnarra,J.R. and Linehan,W.M. (1994) Silencing
of the VHL tumor-suppressor gene by DNA methylation in renal
carcinoma. Proc. Natl Acad. Sci. USA, 91, 9700–9704.
9. Palmisano,W.A., Divine,K.K., Saccomanno,G., Gilliland,F.D.,
Baylin,S.B., Herman,J.G. and Belinsky,S.A. (2000) Predicting lung
cancer by detecting aberrant promoter methylation in sputum.
Cancer Res., 60, 5954–5958.
10. Cui,H., Cruz-Correa,M., Giardiello,F.M., Hutcheon,D.F.,
Kafonek,D.R., Brandenburg,S., Wu,Y., He,X., Powe,N.R. and
Feinberg,A.P. (2003) Loss of IGF2 imprinting: a potential marker of
colorectal cancer risk. Science, 299, 1753–1755.
11. Widschwendter,M. and Jones,P.A. (2002) The potential prognostic,
predictive, and therapeutic values of DNA methylation in cancer.
Clin. Cancer Res., 8, 17–21.
12. Huang,T.H., Perry,M.R. and Laux,D.E. (1999) Methylation profiling of
CpG islands in human breast cancer cells. Hum. Mol. Genet.,
8, 459–470.
13. Wei,S.H., Chen,C.-M., Strathdee,G., Harnsomburana,J., Shyu,C.-R.,
Rahmatpanah,F., Shi,H., Ng,S.-W., Yan,P.S., Nephew,K.P. et al.
(2002) Methylation microarray analysis of late-stage ovarian
carcinomas distinguishes progression-free survival in patients and
identifies candidate epigenetic markers. Clin. Cancer Res.,
8, 2246–2252.
14. Yan,P.S., Chen,C.M., Shi,H., Rahmatpanah,F., Wei,S.H.,
Caldwell,C.W. and Huang,T.H. (2001) Dissecting complex epigenetic
alterations in breast cancer using CpG island microarrays. Cancer
Res., 61, 8375–8380.
15. Yan,P.S., Perry,M.R., Laux,D.E., Asare,A.L., Caldwell,C.W. and
Huang,T.H. (2000) CpG island arrays: an application toward
deciphering epigenetic signatures of breast cancer. Clin.
Cancer Res., 6, 1432–1438.
16. Yan,P.S., Chen,C.-M., Shi,H., Rahmatpanah,F., Wei,S.H. and
Huang,T.H.-M. (2002) Applications of CpG island microarrays
for high-throughput analysis of DNA methylation. J. Nutr.,
132, S2430–S2434.
17. Yan,P.S., Efferth,T., Chen,H.-L., Lin,J., Rodel,F., Fuzesi,L. and
Huang,T.H.-M. (2002) Use of CpG island microarrays to identify
colorectal tumors with a high degree of concurrent methylation.
Methods, 27, 162–169.
18. Cross,S.H., Charlton,J.A., Nan,X. and Bird,A.P. (1994) Purification of
CpG islands using a methylated DNA binding column. Nature Genet.,
6, 236–244.
19. Nouzova,M., Holtan,N., Oshiro,M.M., Isett,R.B.,
Munoz-Rodriguez,J.L., List,A.F., Narro,M.L., Miller,S.J.,
Merchant,N.C. and Futscher,B.W. (2004) Epigenomic changes during
leukemia cell differentiation: analysis of histone acetylation and
cytosine methylation using CpG island microarrays. J. Pharmacol. Exp.
Ther., 311, 968–981.
20. Altschul,S.F., Gish,W., Miller,W., Myers,E.W. and Lipman,D.J. (1990)
Basic local alignment search tool. J. Mol. Biol., 215, 403–410.
21. Stajich,J.E., Block,D., Boulez,K., Brenner,S.E., Chervitz,S.A.,
Dagdigian,C., Fuellen,G., Gilbert,J.G.R., Korf,I., Lapp,H. et al. (2002)
The bioperl toolkit: Perl modules for the life sciences. Genome Res.,
12, 1611–1618.
22. Hubbard,T., Barker,D., Birney,E., Cameron,G., Chen,Y., Clark,L.,
Cox,T., Cuff,J., Curwen,V., Down,T. et al. (2001) The Ensembl
genome database project. Nucleic Acids Res., 30, 38–41.
23. Rouquier,S., Trask,B.J., Taviaux,S., van den Engh,G., Diriong,S.,
Lennon,G.G. and Giorgi,D. (1995) Direct selection of cDNAs using
whole chromosomes. Nucleic Acids Res., 23, 4415–4420.
24. Xiong,Z. and Laird,P.W. (1997) COBRA: a sensitive and quantitative
DNA methylation assay. Nucleic Acids Res., 25, 2532–2534.
25. Sadri,R. and Hornsby,P.J. (1996) Rapid analysis of DNA methylation
using new restriction enzyme sites created by bisulfite modification.
Nucleic Acids Res., 24, 5058–5059.
26. Smyth,G.K. (2004) Linear models and empirical bayes methods for
assessing differential expression in microarray experiments. Stat.
Appl. Genet. Mol. Biol., 3, Article 3.
27. R Development Core Team (2005) R: A Language and Environment
for Statistical Computing. R Foundation for Statistical Computing,
Vienna, Austria. ISBN 3-900051-07-0.
28. Leisch,F. and Rossini,A.J. (2003) Reproducible statistical research.
Chance, 16, 41–45.
29. Hardle,W. and Ronz,B. (eds) (2002) Sweave: dynamic generation of
statistical reports using literature data analysis. In Proceedings of the
conference on Computational Statistics, Berlin. Physika Verlag,
Heidelberg, Germany, pp. 575–580.
30. Gentleman,R. (2004) Reproducible research: a bioinformatics case
study. Stat. Appl. Genet. Mol. Biol., 3.
31. Paz,M.F., Wei,S., Cigudosa,J.C., Rodriguez-Perales,S., Peinado,M.A.,
Huang,T.H.-M. and Esteller,M. (2003) Genetic unmasking of
epigenetically silenced tumor suppressor genes in colon cancer cells
deficient in DNA methyltransferases. Hum. Mol. Genet.,
12, 2209–2219.
32. Lind,G.E., Thorstensen,L., Lovig,T., Meling,G.I., Hamelin,R.,
Rognum,T.O., Esteller,M. and Lothe,R.A. (2004) A CpG island
hypermethylation profile of primary colorectal carcinomas and colon
cancer cell lines. Mol. Cancer, 3, 28.
33. Dudoit,S., Yang,Y.H., Callow,M.J. and Speed,T.P. (2002) Statistical
methods for identifying differentially expressed genes in replicated
cDNA microarray experiments. Statistica Sinica, 12, 111–140.
34. Lonnstedt,I. and Speed,T.P. (2002) Replicated microarray data.
Statistica Sinica, 12, 31–46.
35. Groot,G.S. and Kroon,A.M. (1979) Mitochondrial DNA from various
organisms does not contain internally methylated cytosine in
-CCGG- sequences. Biochim. Biophys. Acta, 564, 355–357.
36. Maekawa,M., Taniguchi,T., Higashi,H., Sugimura,H., Sugano,K. and
Kanno,T. (2004) Methylation of mitochondrial DNA is not a useful
marker for cancer detection. Clin. Chem., 50, 1480–1481.
37. Burden,A.F., Manley,N.C., Clark,A.D., Gartler,S.M., Laird,C.D. and
Hansen,R.S. (2005) Hemimethylation and non-CpG methylation levels
in a promoter region of human LINE-1 (L1) repeated elements.
J. Biol. Chem., 280, 14413–14419.
38. Suzuki,H., Toyota,M., Nojima,M., Mori,M. and Imai,K. (2005) SFRP,
a family of new colorectal tumor suppressor candidate genes.
Nippon Rinsho., 63, 707–719.
39. Antoniou,M., Harland,L., Mustoe,T., Williams,S., Holdstock,J.,
Yague,E., Mulcahy,T., Griffiths,M., Edwards,S., Ioannou,P.A. et al.
(2003) Transgenes encompassing dual-promoter CpG islands from the
human TBP and HNRPA2B1 loci are resistant to
heterochromatin-mediated silencing. Genomics, 82, 269–279.
40. Paz,M.F., Fraga,M.F., Avila,S., Guo,M., Pollan,M., Herman,J.G. and
Esteller,M. (2003b) A systematic profile of DNA methylation in human
cancer cell lines. Cancer Res., 63, 1114–1121.
41. Leu,Y.-W., Yan,P.S., Fan,M., Jin,V.X., Liu,J.C., Curran,E.M.,
Welshons,W.V., Wei,S.H., Davuluri,R.V., Plass,C. et al. (2004) Loss
of estrogen receptor signaling triggers epigenetic silencing of
downstream targets in breast cancer. Cancer Res., 64,
8184–8192.
42. Shi,H., Yan,P.S., Chen,C.-M., Rahmatpanah,F., Lofton-Day,C.,
Caldwell,C.W. and Huang,T.H.-M. (2002) Expressed CpG island
sequence tag microarray for dual screening of DNA hypermethylation
and gene silencing in cancer cells. Cancer Res., 62, 3214–3220.
43. Baker,S.C., Bauer,S.R., Beyer,R.P., Brenton,J.D., Bromley,B.,
Burrill,J., Causton,H., Conley,M.P., Elespuru,R., Fero,M. et al. (2005)
The external RNA controls consortium: a progress report. Nature
Methods, 2, 731–734.
44. Shi,H., Maier,S., Nimmrich,I., Yan,P.S., Caldwell,C.W., Olek,A. and
Huang,T.H.-M. (2003) Oligonucleotide-based microarray for DNA
methylation analysis: principles and applications. J. Cell Biochem., 88,
138–143.
45. Tost,J., Schatz,P., Schuster,M., Berlin,K. and Gut,I.G. (2003) Analysis
and accurate quantification of CpG methylation by MALDI mass
spectrometry. Nucleic Acids Res., 31, e50.
46. Weber,M., Davies,J.J., Wittig,D., Oakeley,E.J., Haase,M., Lam,W.L.
and Schubeler,D. (2005) Chromosome-wide and promoter-specific
analyses identify sites of differential DNA methylation in
normal and transformed human cells. Nature Genet.,
37, 853–862.
PAGE 11 OF 12 Nucleic Acids Research, 2006, Vol. 34, No. 20 e136
 by guest on A
ugust 26, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
47. Ching,T.-T., Maunakea,A.K., Jun,P., Hong,C., Zardo,G., Pinkel,D.,
Albertson,D.G., Fridlyand,J., Mao,J.-H., Shchors,K. et al. (2005)
Epigenome analyses using BAC microarrays identify evolutionary
conservation of tissue-specific methylation of SHANK3.
Nature Genet., 37, 645–651.
48. Wang,Y., Yu,Q., Cho,A.H., Rondeau,G., Welsh,J., Adamson,E.,
Mercola,D. and McClelland,M. (2005) Survey of differentially
methylated promoters in prostate cancer cell lines. Neoplasia,
7, 748–760.
49. Schumacher,A., Kapranov,P., Kaminsky,Z., Flanagan,J.,
Assadzadeh,A., Yau,P., Virtanen,C., Winegarden,N., Cheng,J.,
Gingeras,T. et al. (2006) Microarray-based DNA methylation profiling:
technology and applications. Nucleic Acids Res., 34,
528–542.
50. Wu,H., Chen,Y., Liang,J., Shi,B., Wu,G., Zhang,Y., Wang,D., Li,R.,
Yi,X., Zhang,H. et al. (2005) Hypomethylation-linked activation of
PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.
Nature, 438, 981–987.
e136 Nucleic Acids Research, 2006, Vol. 34, No. 20 PAGE 12 OF 12
 by guest on A
ugust 26, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
